Drug treatment of multiple sclerosis - Clinical review was unsystematic

被引:2
作者
Milne, R [1 ]
Clegg, A [1 ]
Bryant, J [1 ]
机构
[1] Univ Southampton, Wessex Inst Hlth Res & Dev, Southampton SO16 7PX, Hants, England
关键词
D O I
10.1136/bmj.322.7281.299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:299 / 299
页数:1
相关论文
共 4 条
[1]   Cost utility of drugs for multiple sclerosis - Systematic review places study in context [J].
Bryant, J ;
Clegg, A ;
Milne, R .
BRITISH MEDICAL JOURNAL, 2000, 320 (7247) :1474-1475
[2]  
CLEGG A, 2000, HEALTH TECHNOL ASSES, V4, P1
[3]   Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis [J].
Kappos, L ;
Moeri, D ;
Radue, EW ;
Schoetzau, A ;
Schweikert, K ;
Barkhof, F ;
Miller, D ;
Guttmann, CRG ;
Weiner, HL ;
Gasperini, C ;
Filippi, M .
LANCET, 1999, 353 (9157) :964-969
[4]   Regular review - Drug treatment of multiple sclerosis [J].
Polman, CH ;
Uitdehaag, BMJ .
BRITISH MEDICAL JOURNAL, 2000, 321 (7259) :490-494